普洛药业
(000739)
| 流通市值：256.03亿 | | | 总市值：256.13亿 |
| 流通股本：11.58亿 | | | 总股本：11.58亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 4,823,307,257.79 | 2,447,410,940.29 | 9,783,600,915.27 | 7,763,882,133.27 |
| 营业总成本 | 4,195,088,094.34 | 2,132,762,351.94 | 8,789,064,728.76 | 6,996,741,278.28 |
| 其他经营收益 | | | | |
| 营业利润 | 621,747,682.02 | 297,277,004.96 | 1,070,863,560.26 | 842,655,816.16 |
| 利润总额 | 621,618,400.39 | 297,813,987.94 | 1,066,198,868.98 | 839,139,546.78 |
| 净利润 | 522,563,447.12 | 249,276,739.5 | 890,681,701.93 | 700,189,009.91 |
| 每股收益 | | | | |
| 其他综合收益 | 3,120,832.77 | 1,503,555.52 | 300,145.47 | 937,413.11 |
| 综合收益总额 | 525,684,279.89 | 250,780,295.02 | 890,981,847.4 | 701,126,423.02 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 7,801,553,799.97 | 7,892,172,263.76 | 7,878,965,938.3 | 7,585,032,315.13 |
| 非流动资产: | | | | |
| 非流动资产合计 | 4,299,301,329.86 | 4,358,023,993.38 | 4,439,297,353.69 | 4,516,930,484.21 |
| 资产总计 | 12,100,855,129.83 | 12,250,196,257.14 | 12,318,263,291.99 | 12,101,962,799.34 |
| 流动负债: | | | | |
| 流动负债合计 | 4,934,619,960.62 | 5,082,734,367.53 | 5,365,151,090.12 | 5,316,853,533.24 |
| 非流动负债: | | | | |
| 非流动负债合计 | 590,093,376.05 | 598,257,197.64 | 606,763,046.04 | 290,916,547.6 |
| 负债合计 | 5,524,713,336.67 | 5,680,991,565.17 | 5,971,914,136.16 | 5,607,770,080.84 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 6,568,030,909.23 | 6,561,026,246.51 | 6,338,427,056.5 | 6,486,351,400.77 |
| 股东权益合计 | 6,576,141,793.16 | 6,569,204,691.97 | 6,346,349,155.83 | 6,494,192,718.5 |
| 负债和股东权益合计 | 12,100,855,129.83 | 12,250,196,257.14 | 12,318,263,291.99 | 12,101,962,799.34 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 3,572,535,419.08 | 1,875,562,532.84 | 8,544,405,781.59 | 6,293,882,351.31 |
| 经营活动现金流出小计 | 3,498,205,919.68 | 1,750,589,890.57 | 7,324,204,500.84 | 5,519,858,244.64 |
| 经营活动产生的现金流量净额 | 74,329,499.4 | 124,972,642.27 | 1,220,201,280.75 | 774,024,106.67 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,030,186,863.26 | 1,057,022,526.72 | 1,312,869,961.15 | 986,330,907.92 |
| 投资活动现金流出小计 | 1,276,984,373.41 | 1,171,539,631.2 | 1,685,187,950.8 | 1,224,656,435.27 |
| 投资活动产生的现金流量净额 | -246,797,510.15 | -114,517,104.48 | -372,317,989.65 | -238,325,527.35 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 748,068,700 | 240,000,000 | 2,134,900,000 | 1,620,900,000 |
| 筹资活动现金流出小计 | 1,065,604,355 | 226,293,710.75 | 2,777,986,444.15 | 2,190,685,623.07 |
| 筹资活动产生的现金流量净额 | -317,535,655 | 13,706,289.25 | -643,086,444.15 | -569,785,623.07 |
| 汇率变动对现金及现金等价物的影响 | -30,480,895.92 | -16,375,254.92 | -9,951,342.78 | 3,355,523.37 |
| 现金及现金等价物净增加额 | -520,484,561.67 | 7,786,572.12 | 194,845,504.17 | -30,731,520.38 |
| 期末现金及现金等价物余额 | 2,403,805,502.56 | 2,932,076,636.35 | 2,924,290,064.23 | 2,698,713,039.68 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -520,484,561.67 | - | 194,845,504.17 | - |
最新报告期：2026-09-01| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 西部证券 | 李梦园 | 0.92 | 1.14 | 1.39 | 2026-09-01 |
| 招商证券 | 侯彪,梁广楷,许菲菲 | 0.91 | 1.09 | 1.33 | 2026-08-25 |
| 兴业证券 | 孙媛媛,黄翰漾 | 0.91 | 1.13 | 1.40 | 2026-08-24 |
| 中泰证券 | 祝嘉琦 | 0.89 | 1.11 | 1.43 | 2026-08-24 |
| 华创证券 | 郑辰,王宏雨 | 0.93 | 1.12 | 1.41 | 2026-08-21 |